[8-K] eHealth, Inc. Reports Material Event

Rhea-AI Filing Summary

eHealth, Inc. (Nasdaq: EHTH) submitted a Form 8-K on 6 Aug 2025 to furnish, rather than file, its second-quarter 2025 results under Item 2.02.

Highlights

• Exhibit 99.1 contains the full press release covering financial performance for the three and six months ended 30 Jun 2025.
• Exhibit 99.2 provides accompanying conference-call slide materials; both are also available on the company’s investor-relations website.
• Because the data are “furnished,” they are excluded from liability under Exchange Act §18 and are not automatically incorporated into other SEC filings.
• No other material transactions, financial statements, or governance changes were disclosed; the filing is strictly a results announcement conduit.

Insights

SEC Filings Analyst

TL;DR: Routine 8-K furnishes Q2 results; neutral until financial figures are examined.

The company met Reg FD requirements by releasing its Q2 2025 earnings materials via an 8-K and IR website. The absence of numerical data in the core filing limits immediate valuation impact; investors must review Exhibits 99.1/99.2 for revenue, margin, and guidance detail. Classification as “furnished” minimizes legal exposure and signals no change to prior disclosures. Overall, this is standard practice and does not, by itself, alter the investment thesis.

FALSE000133349300013334932025-08-062025-08-06

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (date of earliest event reported): August 6, 2025

EHEALTH, INC.

(Exact Name of Registrant as Specified in its Charter)

Delaware			001-33071			56-2357876
(State or other jurisdiction of incorporation)			(Commission File Number)			(I.R.S. Employer Identification No.)

13620 RANCH ROAD 620 N, SUITE A250

AUSTIN, TX 78717

(Address of principal executive offices)    (Zip Code)

(737) 248-2340

(Registrant’s telephone number, including area code)

Not applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.001 per share

EHTH

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 2.02 Results of Operations and Financial Condition.

On August 6, 2025, eHealth, Inc. (the “Company”) issued a press release announcing its financial results for the three and six months ended June 30, 2025 and its financial condition as of June 30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

On August 6, 2025, the Company posted supplemental investor material on its investor relations webpage at https://ir.ehealthinsurance.com. The Company intends to use its investor relations webpage as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. A copy of the supplemental investor materials is also furnished as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated herein by reference.

The information in Item 2.02 of this Current Report on Form 8-K and the exhibits attached hereto are intended to be “furnished” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. Except as shall be expressly set forth by specific reference in such filing, the information contained herein and in the accompanying exhibits shall not be incorporated by reference into any filing with the Securities and Exchange Commission made by the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Item 9.01  Financial Statements and Exhibits.

(d)    Exhibits

Exhibit No.			Description
99.1			Press Release of eHealth, Inc. dated August 6, 2025 (eHealth, Inc. Announces Second Quarter 2025 Results)
99.2			Financial Results Conference Call Slides of eHealth, Inc. dated August 6, 2025
104			Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

						eHealth, Inc.
Date:			August 6, 2025			/s/ John Dolan
						John Dolan Chief Financial Officer (Principal Financial Officer)

FAQ

Where can investors find eHealth's Q2 2025 financial figures?

Full results are in Exhibit 99.1 of the Form 8-K and on the company's IR website.

What additional materials did eHealth (EHTH) release with the 8-K?

A slide deck for the earnings call was furnished as Exhibit 99.2.

Does the 8-K include audited financial statements?

No. The information is furnished, not filed; it contains no audited statements.

Were any other material events announced in this filing?

No. The filing solely relates to the release of Q2 2025 earnings information.